MLL-SEPTIN gene fusions in hematological malignancies

Biological Chemistry

Volumn 392, Issue 8-9, 2011, Pages 713-724

  Cerveira, Nuno ^a   Bizarro, Susana ^a   Teixeira, Manuel R ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

fusion genes; hematological malignancies; MLL; septins

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA METHYLTRANSFERASE; EPIPODOPHYLLOTOXIN; GYRASE INHIBITOR; HISTONE H3; HISTONE H3 LYSINE 4; HYBRID PROTEIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; METHIONINE; MIXED LINEAGE LEUKEMIA PROTEIN; MIXED LINEAGE LEUKEMIA SEPTIN FUSION PROTEIN; SEPTIN; SEPTIN 11; SEPTIN 2; SEPTIN 5; SEPTIN 6; SEPTIN 9; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE OUTCOME; CANCER CHEMOTHERAPY; CANCER RISK; CHILDHOOD CANCER; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL ASSESSMENT; CONFERENCE PAPER; DROSOPHILA MELANOGASTER; GENE DUPLICATION; GENE FUSION; GENE INSERTION; GENETIC ASSOCIATION; HUMAN; LEUKEMIA; NEOPLASM; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TREATMENT OUTCOME;

GENE FUSION; HEMATOLOGIC NEOPLASMS; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; SEPTINS;

EID: 80052784488     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.072     Document Type: Conference Paper

References (111)

1. Alexander, F.E., Patheal, S.L., Biondi, A., Brandalise, S., Cabrera, M.E., Chan, L.C., Chen, Z., Cimino, G., Cordoba, J.C., Gu, L.J., et al. (2001). Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 61, 2542-2546. (Pubitemid 32685836)
2. Arai, M., Dyson, H.J., and Wright, P.E. (2010). Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain. FEBS Lett. 584, 4500-4504.
3. Arber, D.A., Brunning, R.D., Le Beau, M.M., and Falini B. (2008). Acute myeloid leukaemia with recurrent genetic abnormalities. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman, eds. (Lyon, France: WHO Press), pp. 110-123.
4. Ayton, P.M. and Cleary, M.L. (2001). Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene20, 5695-5707. (Pubitemid 32928107)
5. Ayton, P.M., Chen, E.H., and Cleary, M.L. (2004). Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell. Biol. 24, 10470-10478. (Pubitemid 39507883)
6. Bielorai, B., Meyer, C., Trakhtenbrot, L., Golan, H., Rozner, E., Amariglio, N., Izraeli, S., Marschalek, R., and Toren, A. (2010). Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma. Cancer Genet. Cytogen. 203, 288-291.
7. Biondi, A., Cimino, G., Pieters, R., and Pui, C.H. (2000). Biological and therapeutic aspects of infant leukemia. Blood 96, 24-33. (Pubitemid 30456446)
8. Borkhardt, A., Teigler-Schlegel, A., Fuchs, U., Keller, C., König, M., Harbott, J., and Haas, O.A. (2001). An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML-M2. Gene Chromosome Cancer 32, 82-88. (Pubitemid 32737787)
9. Briggs, S.D., Bryk, M., Strahl, B.D., Cheung, W.L., Davie, J.K., Dent, S.Y., Winston, F., and Allis, C.D. (2001). Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev. 15, 3286-3295. (Pubitemid 34008193)
10. Burnett, A., Wetzler, M., and Löwenberg, B. (2011). Therapeutic advances in acute myeloid leukemia. J. Clin. Oncol. 29, 487-494.
11. Cerveira, N., Correia, C., Bizarro, S., Pinto, C., Lisboa, S., Mariz, J.M., Marques, M., and Teixeira, M.R. (2006). SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 25, 6147-6152. (Pubitemid 44562414)
12. Cerveira, N., Meyer, C., Santos, J., Torres, L., Lisboa, S., Pinheiro, M., Bizarro, S., Correia, C., Norton, L., Marschalek, R., et al. (2010). A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia. BMC Cancer 10, 518.
13. Cerveira, N., Micci, F., Santos, J., Pinheiro, M., Correia, C., Lisboa, S., Bizarro, S., Norton, L., Glomstein, A., Åsberg, A.E., et al. (2008a). Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions. Haematologica 93, 1076-1080. (Pubitemid 351957026)
14. Cerveira, N., Santos, J., Pinheiro, M., Snijder, S., van der Lelie, H., Mellink C., and Teixeira, M.R. (2008b). A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome. Cancer Genet. Cytogenet. 185, 62-64.
15. Cerveira, N., Santos, J., Bizarro, S., Costa, V., Ribeiro, F.R., Lisboa, S., Correia, C., Torres, L., Vieira, J., Snijder, S., et al. (2009). Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy- related myeloid neoplasia. BMC Cancer 9, 147.
16. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A., et al. (1997). Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404-407.
17. Chen, C.S., Sorensen, P.H., Domer, P.H., Reaman, G.H., Korsmeyer, S.J., Heerema, N.A., Hammond, G.D., and Kersey, J.H. (1993). Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81, 2386-2393. (Pubitemid 23127075)
18. Chen, S.H., Yang, C.P., Hung, I.J., Jaing, T.H., Shih, L.Y., and Tsai, M.H. (2010). Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan. Pediatr. Blood Cancer 55, 1264-1271.
19. Cimino, G., Rapanotti, M.C., Biondi, A., Elia, L., Lo Coco, F., Price, C., Rossi, V., Rivolta, A., Canaani, E., Croce, C.M., et al. (1997). Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res. 57, 2879-2883. (Pubitemid 27315032)
20. Daser, A. and Rabbitts, T.H. (2005). The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin. Cancer Biol. 15, 175-188.
21. De Braekeleer, E., Meyer, C., Douet-Guilbert, N., Morel, F., Le Bris, M.J., Berthou, C., Arnaud, B., Marschalek, R., Feec, C., and De Braekeleer, M. (2010). Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature. Blood Cell Mol. Dis. 44, 268-274.
22. DiMartino, J.F. and Cleary, M.L. (1999). MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br. J. Haematol. 106, 614-626. (Pubitemid 29434198)
23. DiMartino, J.F., Ayton, P.M., Chen, E.H., Naftzger, C.C., Young, B.D., and Clearly, M.L. (2002). The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99, 3780-3785. (Pubitemid 34534551)
24. DiMartino, J.F., Miller, T., Ayton, P.M., Landewe, T., Hess, J.L., Clearly, M.L., and Shilatifard, A. (2000). A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96, 3887-3893.
25. Dou, Y., Milne, T.A., Tackett, A.J., Smith, E.R., Fukuda, A.,Wysocka, J., Allis, C.D., Chait, B.T., Hess, J.L., and Roeder, R.G. (2005). Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 cetyltransferase MOF. Cell 121, 873-885. (Pubitemid 40806419)
26. Dreyling, M.H., Schrader, K., Fonatsch, C., Schlegelberger, B., Haase, D., Schoch, C., Ludwig, W., Löffler, H., Büc hner, T., Wörmann, B., et al. (1998). MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 91, 4662-4667. (Pubitemid 28270315)
27. Ernst, P., Wang, J., Huang, M., Goodman, R.H., and Korsmeyer, S.J. (2001). MLL and CREB bind cooperatively to the nuclear coactivator CREβ-binding protein. Mol. Cell. Biol. 21, 2249-2258. (Pubitemid 32222079)
28. Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., and Diaz, M.O. (2001). Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol. Cell. Biol. 21, 3589-3597. (Pubitemid 32381794)
29. Felix, C.A., Hosler, M.R., Winick, N.J., Masterson, M., Wilson, A.E., and Lange, B.J. (1995). ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85, 3250-3256.
30. Fu, J.F., Liang, D.C., Yang, C.P., Hsu, J.J., and Shih, L.Y. (2003). Molecular analysis of t(X;11)(q24;q23) in an infant with AMLM4. Gene Chromosome Cancer 38, 253-259.
31. Gillert, E., Leis, T., Repp, R., Reichel, M., Hösch, A., Breitenlohner, I., Angermüller, S., Borkhardt, A., Harbott, J., Lampert, F., et al. (1999). A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18, 4663-4671. (Pubitemid 29417741)
32. Gladfelter, A.S. and Montagna, C. (2007). Seeking truth on Monte Verita. Workshop on the molecular biology and biochemistry of septins and septin function. EMBO Rep. 8, 1120-1126. (Pubitemid 350201728)
33. Grier, D.G., Thompson, A., Kwasniewska, A., McGonigle, G.J., Halliday, H.L., and Lappin, T.R. (2005). The pathophysiology of HOX genes and their role in cancer. J. Pathol. 205, 154-171. (Pubitemid 40227988)
34. Hall, P.A. and Russell, S.E. (2004). The pathobiology of the septin gene family. J. Pathol. 204, 489-505. (Pubitemid 39468160)
35. Harrison, C.J., Haas, O., Harbott, J., Biondi, A., Stanulla, M., Trka, J., and Izraeli, S. (2010). Detection of prognostically relevant genetic abnormalities in childhood β-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster Study Group. Br. J. Haematol. 151, 132-142.
36. Hall, P.A., Jung, K., Hillan, K.J., and Russell, S.E. (2005). Expression profiling the human septin gene family. J. Pathol. 206, 269-278. (Pubitemid 40903191)
37. Hess, J.L. (2004). MLL: a histone methyltransferase disrupted in leukemia. Trends Mol. Med. 10, 500-507. (Pubitemid 39303623)
38. Hsieh, J.J., Cheng, E.H., and Korsmeyer, S.J. (2003a). Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell 115, 293-303. (Pubitemid 37487703)
39. Hsieh, J.J., Ernst, P., Erdjument-Bromage, H., Tempst, P., and Korsmeyer, S.J. (2003b). Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization. Mol. Cell. Biol. 23, 186-194. (Pubitemid 36008512)
40. Hughes, C.M., Rozenblatt-Rosen, O., Milne, T.A., Copeland, T.D., Levine, S.S., Lee, J.C., Hayes, D.N., Shanmugam, K.S., Bhattacharjee, A., Biondi, C.A., et al. (2004). Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13, 587-597. (Pubitemid 38299385)
41. Huret, J.L., Senon, S., Bernheim, A., and Dessen, P. (2004). An Atlas on genes and chromosomes in oncology and haematology. Cell. Mol. Biol. 50, 805-807.
42. Ida, K., Kitabayashi, I., Taki, T., Taniwaki, M., Noro, K., Yamamoto, M., Ohki, M., and Hayashi, Y. (1997). Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia witht(11;22)(q23;q13). Blood 90, 4699-4704. (Pubitemid 28007181)
43. Imamura, T., Morimoto, A., Takanashi, M., Hibi, S., Sugimoto, T., Ishii, E., and Imashuku, S. (2002). Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement. Br. J. Haematol. 119, 119-121. (Pubitemid 35176508)
44. Jude, C., Climer, L., Xu, D., Artinger, E., Fisher, J., and Ernst, P. (2007). Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell 1, 324-337. (Pubitemid 47355322)
45. Kadkol, S.S., Bruno, A., Oh, S., Schmidt, M.L., and Lindgren, V. (2006). MLL-SEPT6 fusion transcript with a novel sequence in an infant with acute myeloid leukemia. Cancer Genet. Cytogenet. 168, 162-167.
46. Kim, H.J., Ki, C.S., Parkm Q., Koo, H.H., Yoo, K.H., Kim, E.J., and Kim, S.H. (2003). MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature. Gene Chromosome Canc. 38, 8-12.
47. Kojima, K., Sakai, I., Hasegawa, A., Niiya, H., Azuma, T., Matsuo, Y., Fujii, N., Tanimoto, M., and Fujita, S. (2004). FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia 18, 998-1005. (Pubitemid 38714626)
48. Kreuziger, L.M.B., Porcher, J.C., Ketterling, R.P., and Steensma, D.P. (2007). An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk. Res. 31, 1145-1148.
49. Krivtsov, A.V. and Armstrong, S.A. (2007). MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823-833. (Pubitemid 350006257)
50. Kumar, A.R., Hudson, W.A., Chen, W., Nishiuchi, R., Yao, Q., and Kersey, J.H. (2004). Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood 103, 1823-1828. (Pubitemid 38268979)
51. Kurosu, T., Tsuji, K., Ohki, M., Miki, T., Yamamoto, M., Kakihana, K., Koyama, T., Taniguchi, S., and Miura, O. (2008). A varianttype MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int. J. Hematol. 88, 192-196.
52. Leipe, D.D., Wolf, Y.I., Koonin, E.V., and Aravind, L. (2002). Classification and evolution of P-loop GTPases and related ATPases. J. Mol. Biol. 317, 41-72. (Pubitemid 34722199)
53. Lillington, D.M., Young, B.D., Berger, R., Martineau, M., Moorman, A.V., and Secker-Walker, L.M. (1998). The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants. Leukemia 12, 801-804. (Pubitemid 28220839)
54. Liu, H., Takeda, S., Cheng, E.H., and Hsieh, J.J. (2008). Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia. Cell Cycle 7, 428-435. (Pubitemid 351366467)
55. Malik, S. and Bhaumik, S.R. (2010). Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human. FEBS J. 277, 1805-1821.
56. Marschalek, R. (2010). Mixed lineage leukemia: roles in human malignancies and potential therapy. FEBS J. 277, 1822-1831.
57. Marschalek, R. (2011). Mechanisms of leukemogenesis by MLL fusion proteins. Br. J. Haematol. 152, 141-154.
58. McMahon, K.A., Hiew, S.Y., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A.J., Kioussis, D., Williams, O., and Brady, H.J. (2007). Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell 1, 338-345. (Pubitemid 47355325)
59. Megonigal, M.D., Rappaport, E.F., Jones, D.H., Williams, T.M., Lovett, B.D., Kelly, K.M., Lerou, P.H., Moulton, T., Budarf, M.L, and Felix, C.A. (1998). t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in Di- George and velocardiofacial syndromes. Proc. Natl. Acad. Sci. USA 95, 6413-6418. (Pubitemid 28249027)
60. Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M.W., van Dongen, J.J., den Boer, et al. (2006). The MLL recombinome of acute leukemias. Leukemia 20, 777-784.
61. Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., et al. (2009). New insights to the MLL recombinome of acute leukemias. Leukemia 23, 1490-1499.
62. Milne, T.A., Briggs, S.D., Brock, H.W., Martin, M.E., Gibbs, D., Allis, C.D., and Hess, J.L. (2002). MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107-1117. (Pubitemid 35453828)
63. Milne, T.A., Dou, Y., Martin, M.E., Brock, H.W., Roeder, R.G., and Hess, J.L. (2005). Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Proc. Natl. Acad. Sci. USA 102, 14765-14770.
64. Mohan, M., Lin, C., Guest, E., and Shilatifard, A. (2010). Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nat. Rev. Cancer 10, 721-728.
65. Mróz ek, K., Heinonen, K., Lawrence, D., Carroll, A.J., Koduru, P.R., Rao, K.W., Strout, M.P., Hutchison, R.E., Moore, J.O., Mayer, R.J., et al. (1997). Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 90, 4532-4538. (Pubitemid 27508459)
66. Muntean, A.G., Giannola, D., Udager, A.M., and Hess, J.L. (2008). The PHD fingers of MLL block MLL fusion protein-mediated transformation. Blood 112, 4690-4693.
67. Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C. M., and Canaani, E. (2002). ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119-1128. (Pubitemid 35453829)
68. Ono, R., Ihara, M., Nakajima, H., Ozaki, K., Kataoka-Fujiwara, Y., Taki, T., Nagata, K., Inagaki, M., Yoshida, N., Kitamura, T., et al. (2005a). Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLLSEPT6, or phenotype induced by the loss of Sept4. Mol. Cell. Biol. 25, 10965-10978. (Pubitemid 41747139)
69. Ono, R., Nakajima, H., Ozaki, K., Kumagai, H., Kawashima, T., Taki, T., Kitamura, T., Hayashi, Y., and Nosaka, T. (2005b). Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. J. Clin. Invest. 115, 919-129.
70. Ono, R., Taki, T., Taketani, T., Kawaguchi, H., Taniwaki, M., Okamura, T., Kawa, K., Hanada, R., Kobayashi, M., and Hayashi, Y. (2002). SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. Cancer Res. 62, 333-337. (Pubitemid 34106397)
71. Osaka, M., Rowley, J.D., and Zeleznik-Le, N.J. (1999). MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapyrelated acute myeloid leukemia with a t(11;17)(q23;q25). Proc. Natl. Acad. Sci. USA 96, 6428-6433. (Pubitemid 29256682)
72. Park, T.S., Lee, S.G., Song, J., Lee, K.A., Kim, J., Choi, J.R., Lee, S.T., Marschalek, R., and Meyer, C. (2009). CASP8AP2 is a novel partner gene of MLL rearrangement with t(6;11)(q15;q23) in acute myeloid leukemia. Cancer Genet. Cytogenet. 195, 94-95.
73. Peterson, E.A., Kalikin, L.M., Steels, J.D., Estey, M.P., Trimble, W.S., and Petty, E.M. (2007). Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mamm. Genome 18, 796-807. (Pubitemid 350160087)
74. Pineault, N., Helgason, C.D., Lawrence, H.J., and Humphries, R.K. (2002). Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp. Hematol. 30, 49-57. (Pubitemid 34059217)
75. Popovic, R. and Zeleznik-Le, N.J. (2005). MLL: how complex does it get? J. Cell. Biochem. 95, 234-242.
76. Pui, C.H. and Relling, M.V. (2000). Topoisomerase II inhibitor-related acute myeloid leukaemia. Br. J. Haematol. 109, 13-23. (Pubitemid 30340574)
77. Richardson, C. and Jasin, M. (2000). Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697-700. (Pubitemid 30428657)
78. Rubnitz, J.E., Raimondi, S.C., Tong, X., Srivastava, D.K., Razzouk, B.I., Shurtleff, S.A., Downing, J.R., Pui, C.H., Ribeiro, R.C., and Behm, F.G. (2002). Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J. Clin. Oncol. 20, 2302-2 309.
79. Russell, S.E. and Hall, P.A. (2005). Do septins have a role in cancer? Br. J. Cancer 93, 499-503.
80. Saito, H., Otsubo, K., Kakimoto, A., Komatsu, N., and Ohsaka, A. (2010). Emergence of two unrelated clones in acute myeloid leukemia with MLL-SEPT9 fusion transcript. Cancer Genet. Cytogenet. 201, 111-115.
81. Santos, J., Cerveira, N., Bizarro, S., Ribeiro, F.R., Correia, C., Torres, L., Lisboa, S., Vieira, J., Mariz, J.M., Norton, L., et al. (2010a). Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes. Leuk. Res. 34, 615-621.
82. Santos, J., Cerveira, N., Correia, C., Lisboa, S., Torres, L., Pinheiro, M., Bizarro, S., Viterbo, L., Mariz, J.M., and Teixeira, M.R. (2010b). Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25). Cancer Genet. Cytogenet. 197, 60-64.
83. Shih, L.Y., Liang, D.C., Fu, J.F., Wu, J.H., Wang, P.N., Lin, T.L., Dunn, P., Kuo, M.C., Tang, T.C., Lin, T.H., et al. (2006). Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 20, 218-223. (Pubitemid 43148658)
84. Sirajuddin, M., Farkasovsky, M., Hauer, F., Küh lmann, D., Macara, I.G., Weyand, M., Stark, H., and Wittinghofer, A. (2007). Structural insight into filament formation by mammalian septins. Nature 449, 311-315. (Pubitemid 47443471)
85. Slany, R.K. (2009). The molecular biology of mixed lineage leukemia. Haematologica 94, 984-993.
86. Slater, D.J., Hilgenfeld, E., Rappaport, E.F., Shah, N., Meek, R.G., Williams, W.R., Lovett, B.D., Osheroff, N., Autar, R.S., Ried, T., et al. (2002). MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene 21, 4706-4714. (Pubitemid 34833149)
87. Snijder, S., Mellink, C.H.M., and van der Lelie, H. (2008). Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Cancer Genet. Cytogenet. 180, 149-152.
88. So, C.W., Karsunky, H., Wong, P., Weissman, I.L., and Cleary, M.L. (2004). Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood 103, 3192-3199. (Pubitemid 38451698)
89. So, C.W., Lin, M., Ayton, P.M., Chen, E.H., and Cleary, M.L. (2003). Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 4, 99-110. (Pubitemid 37040826)
90. Spiliotis, E.T. and Nelson, W.J. (2006). Here come the septins: novel polymers that coordinate intracellular functions and organization. J. Cell Sci. 19, 4-10. (Pubitemid 43169293)
91. Stam, R.W., Schneider, P., Hagelstein, J.A., van der Linden, M.H., Stumpel, D.J., de Menezes, R.X., de Lorenzo, P., Valsecchi, M.G., and Pieters, R. (2010). Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood 115, 2835-2844.
92. Stevens, S.J., Meers, L.E., Albrechts, J.C., Mebis-Verhees, K., Bos, G.M., Engelen, J.J., and Janssen, J.W. (2010). A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-AFF1 translocation and fuses SEPT11 to MLL. Cancer Genet. Cytogenet. 201, 48-51.
93. Strehl, S., König, M., Meyer, C., Schneider, B., Harbott, J., Jäg er, U., von Bergh, A.R.M., Loncarevic, I.F., Jarosova, M., Schmidt, H.H., et al. (2006). Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chromosomes Cancer 45, 1041-1049. (Pubitemid 44435538)
94. Strick, R., Strissel, P.L., Borgers, S., Smith, S.L., and Rowley, J.D. (2000). Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. USA 97, 4790-4795. (Pubitemid 30238636)
95. Strissel, P.L., Strick, R., Rowley, J.D., and Zeleznik-Le, N.J. (1998). An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92, 3793-3803. (Pubitemid 28525206)
96. Swansbury, G.J., Slater, R., Bain, B.J., Moorman, A.V., and Secker- Walker, L.M. (1998). Hematological malignancies with t(9;11)(p21-22;q23) - a laboratory and clinical study of 125 cases. European 11q23 Workshop participants. Leukemia 12, 792-800. (Pubitemid 28220838)
97. Taki, T., Sako, M., Tsuchida, M., and Hayashi, Y. (1997). The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89, 3945-3950. (Pubitemid 27220937)
98. Taki, T., Ohnishi, H., Shinohara, K., Sako, M., Bessho, F., Yanagi sawa, M., and Hayashi, Y. (1999). AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res. 59, 4261-4265. (Pubitemid 29418740)
99. Tamai, H. and Inokuchi, K. (2010). 11q23/MLL acute leukemia: update of clinical aspects. J. Clin. Exp. Hematop. 50, 91-98.
100. Tatsumi, K., Taki, T., Taniwaki, M., Nakamura, H., Taguchi, J., Chen, Y.Z., Bessho, F., Yanagisawa, M., and Hayashi, Y. (2001). The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines. Genes Chromosomes Cancer 30, 230-235. (Pubitemid 32126198)
101. Terranova, R., Agherbi, H., Boned, A., Meresse, S., and Djabali, M. (2006). Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc. Natl. Acad. Sci. USA 103, 6629-6634.
102. van Binsbergen, E., de Weerdt, O., and Buijs, A. (2007). A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review. Cancer Genet. Cytogenet. 176, 72-75. (Pubitemid 46899213)
103. Versele, M. and Thorner, J. (2005). Some assembly required: yeast septins provide the instruction manual. Trends Cell Biol. 15, 414-424. (Pubitemid 41125773)
104. Wang, G.G., Pasillas, M.P., and Kamps, M.P. (2006). Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol. Cell. Biol. 26, 3902-3916. (Pubitemid 43726406)
105. Weirich, C.S., Erzberger, J.P., and Barral, Y. (2008). The septin family of GTPases: architecture and dynamics. Nat. Rev. Mol. Cell. Biol. 9, 478-489. (Pubitemid 351733401)
106. Yamamoto, K., Shibata, F., Yamaguchi, M., and Miura, O. (2002). Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25). Int. J. Hematol. 75, 503-507.
107. Yano, T., Nakamura, T., Blechman, J., Sorio, C., Dang, C.V., Geiger, B., and Canaani, E. (1997). Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein. Proc. Natl. Acad. Sci. USA 94, 7286-7291. (Pubitemid 27345307)
108. Yokoyama, A., Kitabayashi, I., Ayton, P.M., Cleary, M.L., and Ohki, M. (2002). Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100, 3710-3718. (Pubitemid 35303943)
109. Yokoyama, A. and Cleary, M.L. (2008). Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14, 36-46. (Pubitemid 351885493)
110. Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D.J., Kitabayashi, I., Herr, W., and Cleary, M.L. (2004). Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24, 5639-5649. (Pubitemid 38787950)
111. Zeisig, B.B., Milne, T., García-Cuéllar, M.P., Schreiner, S., Martin, M.E., Fuchs, U., Borkhardt, A., Chanda, S.K., Walker, J., Soden, R., et al. (2004). Hoxa9 and Meis1 are key targets for MLLENL- mediated cellular immortalization. Mol. Cell. Biol. 24, 617-628. (Pubitemid 38057914)